Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Influence of VEGF Genetic Polymorphism on Peritoneal Solute Transport in Pediatric Dialysis Patients

소아 복막투석환자에서 혈관내피성장인자 유전자 다형성이 복막의 용질이동성에 미치는 영향

  • Choi, Hyun-Jin (Department of Preventive Medicine, College of Medicine, Seoul National University) ;
  • Paik, Kyung-Hoon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Cho, Hee-Yeon (Division of Vaccine Preventable Disease Control and National Immunization Program) ;
  • Kang, Hee-Kyung (Korean Centers for Disease Control and Prevention Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Cheong, Hae-Il (Korean Centers for Disease Control and Prevention Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Choi, Yong (Department of Pediatrics, Inje University Haeundae Paik Hospital) ;
  • Ha, Il-Soo (Korean Centers for Disease Control and Prevention Department of Pediatrics, Seoul National University Children's Hospital)
  • 최현진 (서울대학교 의과대학 예방의학교실) ;
  • 백경훈 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 조희연 (질병관리본부 예방접종관리과) ;
  • 강희경 (서울대학교 어린이병원 소아청소년과) ;
  • 정해일 (서울대학교 어린이병원 소아청소년과) ;
  • 최용 (인제대학교 해운대 백병원 소아청소년과) ;
  • 하일수 (서울대학교 어린이병원 소아청소년과)
  • Received : 2010.09.20
  • Accepted : 2010.10.09
  • Published : 2010.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Genetic and clinical factors can influence the permeability of the peritoneal membrane. The peritoneal equilibration test (PET) is helpful in measuring peritoneal permeability in peritoneal dialysis (PD). We investigated the influence of genetic polymorphism of vascular endothelial growth factor (VEGF) on the PET parameters. Methods : Pediatric patients who underwent PET within 12 months of initiating PD at Seoul National University Children's Hospital and Samsung Medical Center were selected. The patients with positive history of peritonitis before PET were excluded. The VEGF -2578C/A, -14978T/C, -1154G/A, -634G/C, and +936C/T single-nucleotide polymorphisms were genotyped. Results : The mean 4-hour dialysate-to-plasma ratio for creatinine (D/P creatinine) and the mean 4-hour dialysate glucose to baseline dialysate glucose ratio (D/$D_0$ glucose) were $0.56{\pm}0.13$ and $0.43{\pm}0.11$, respectively. The patients with haplotype CTGGC showed higher 4-hour D/P creatinine ($0.67{\pm}0.12$ vs $0.50{\pm}0.09$, P=0.007) and lower 4-hour D/$D_0$ glucose ($0.35{\pm}0.12$ vs $0.47{\pm}0.08$, P=0.037) than those without haplotype CTGGC. Conclusion : The VEGF genetic polymorphism may influence the peritoneal solute transport.

목 적 : 복막투석환자에서 복막의 용질이동성에 영향을 미치는 요인으로 유전적 요인과 임상적 요인이 있다. 복막평형검사는 복막투석환자의 복막 용질이동속도를 평가하는 데에 유용한 검사로, 본 연구에서는 소아 복막투석 환자에서 복막평형검사 결과를 이용하여 혈관내피성장인자(VEGF)의 유전자 다형성과 복막 용질이동성의 상관관계를 연구하였다. 방 법 : 서울대학교 어린이병원과 삼성서울병원의 소아 복막투석환자 중에서 복막염의 병력이 없고 복막투석 시작한 지 1년 이내에 복막평형검사가 시행된 환자를 대상으로 하였다. VEGF 유전자 -2578 C/A, -14978T/C, -1154G/A, -634G/C, +936 C/T의 단일 유전자다형성분석을 시행하였고 VEGF 유전자 다형성의 분포와 복막평형검사 결과간의 상관관계를 분석하였다. 결 과 : 복막평형검사를 분석한 결과, 4시간 크레아티닌의 투석액/혈장비(D/P creatinine)는 $0.56{\pm}0.13$였고 4시간 투석액/0시간투석액포도당비(D/$D_0$ glucose)는 $0.43{\pm}0.11$였다. 배수체 CTGGC의 이형접합체 또는 동형접합체인 경우가 배수체 CTGGC를 가지지 않은 경우에 비해 높은 4시간 D/P creatinine ($0.67{\pm}0.12$ vs $0.50{\pm}0.09$, P=0.007)과 은 4시간 D/$D_0$ glucose ($0.35{\pm}0.12$ vs $0.47{\pm}0.08$, P=0.037)를 보였다. 결 론 : VEGF 유전자 다형성은 복막 용질이동성에 영향을 미칠 수 있다.

Keywords

References

  1. Twardowski ZJ, Nolph KO, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Int 1987; 7:138-48.
  2. Warady BA, Alexander SR, Hossli S, Vonesh E, Geary D, Watkins S, et al. Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 1996;7:2385-91.
  3. Yoshino A, Honda M, Fukuda M, Araki Y, Hataya H, Sakazume S, et al. Changes in peritoneal equilibration test values during long-term peritoneal dialysis in peritonitisfree children. Perit Dial Int 2001;21:180-5.
  4. Davies SJ. Peritoneal solute transport--we know it is important, but what is it? Nephrol Dial Transplant 2000;15:1120-3. https://doi.org/10.1093/ndt/15.8.1120
  5. Combet S, Miyata T, Moulin PV. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000;11:717- 28.
  6. Margetts PJ, Churchill DN. Acquired ultrafiltration dysfunction in peritoneal dialysis patients. J Am Soc Nephrol 2002;13:2787-94.
  7. Miyata T, Devuyst O, Kurokawa K, Van Ypersele De Strihou C. Toward better dialysis compatibility: Advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002;61:375-86. https://doi.org/10.1046/j.1523-1755.2002.00135.x
  8. Gillerot G, Devuyst O. Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis. Clin Nephrol 2003;60: 1-6. https://doi.org/10.5414/CNP60001
  9. Pecoits-Filho R, Araujo MRT, Lindholm B, Stenvinkel P, Abensur H, Romao JE, Jr., et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002;17:1480-6. https://doi.org/10.1093/ndt/17.8.1480
  10. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW. Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004;43:492-501. https://doi.org/10.1053/j.ajkd.2003.11.010
  11. Passlick-Deetjen J, Chlebowski H, Koch M, Grabensee B. Changes of peritoneal membrane function during long-term CAPD. Adv Perit Dial 1990;6:35-43.
  12. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004;66:2437-45. https://doi.org/10.1111/j.1523-1755.2004.66021.x
  13. Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney International 2005;67:2477-87. https://doi.org/10.1111/j.1523-1755.2005.00357.x
  14. Wong T, Szeto C-C, Szeto C, Lai K-B, Chow K-M, Li P. Association of ENOS polymorphism with basal peritoneal membrane function in uremic patients. Am J Kidney Dis 2003;42:781-6. https://doi.org/10.1016/S0272-6386(03)00855-2
  15. Szeto C-C, Chow K-M, Poon P, Szeto CY-K, Wong TY-H, Li PK-T. Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Kidney Int 2004;65:1947-55. https://doi.org/10.1111/j.1523-1755.2004.00605.x
  16. Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008;111:157-63. https://doi.org/10.1007/s10549-007-9755-9
  17. Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12:1232-35. https://doi.org/10.1006/cyto.2000.0692
  18. Renner W, Kotschan S, Hoffmann C, Ober mayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-8. https://doi.org/10.1159/000054076
  19. Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13:260-4.